Fund

The fund has the mandate to invest in four sector focused areas Healthcare, Life Sciences, Performance Materials and New Businesses, in alignment with the strategic interests of Merck KGaA, Darmstadt, Germany’s business areas, though formally separated by a “Chinese Wall”. The total volume of the corporate venture fund is € 400 million.

Healthcare

We invest globally in emerging biotechnology companies that develop products and or technologies that have the potential to significantly improve patient outcomes.

Healthcare Team

more about
Cheryl Zimberlin
Investment Director
more about
Hakan Goker
Managing Director
more about
Therese Liechtenstein
Investment Director
more about
Noga Yerushalmi
Israel Incubator
more about
Bauke Anninga
Principal
more about
Wallace LE Wallace
Associate

The Healthcare team also manages the Entrepreneur Partnership Program which was established to support the creation of spin-offs from Merck KGaA, Darmstadt, Germany and the Israel Bioincubator, which is focused on pre-seed and seed opportunities coming out of Israel.

The Israel Bioincubator is a strategic initiative designed to stimulate innovation by bridging the gap between academic research and the biotechnology industry in Israel. Launched in 2011 to offers invest in biomedical innovation in Israel, the Bioincubator both seed financing and access to dedicated laboratory facilities within our Israel based R&D center.

Companies

more about
Actithera
more about
Anavo
more about
Artios
more about
Asceneuron
more about
Bird Rock Bio
more about
Calypso Biotech
more about
Forendo Therapeutics
more about
FoRx Therapeutics
more about
Future Fertility
more about
Immunitas
more about
Immunorizon
more about
Inthera
more about
iOmx Therapeutics
more about
iOnctura
more about
Macrophage Pharma
more about
Metabomed LTD
more about
Outrun Therapeutics
more about
Rewind Therapeutics
more about
ribometrix
more about
Sentaur Biosciences
more about
Soteria
more about
Synaffix BV
more about
Storm Therapeutics
more about
Theolytics
more about
Vaximm

Life Science

The Life Science Team invests in areas of strategic value to the life science division of Merck KGaA, Darmstadt, Germany.

Life Science Team

more about
Cheryl Zimberlin
Investment Director
more about
Hakan Goker
Managing Director
more about
Javier Rodriguez
more about
Therese Liechtenstein
Investment Director
more about
Christian Uhrich
Principal
more about
Arnaud Autret
Investment Director
more about
Noga Yerushalmi
Israel Incubator
more about
Anique ter Braake
Associate
more about
Bauke Anninga
Principal
more about
Jonathan Nash
Associate
more about
Wallace LE Wallace
Associate
more about
Nadiya Ishnazarova
Associate
more about
Björn Kuhl
Head of Operations

In Life Sciences, we are instrumental in building world class Life Science companies that develop tools, technologies and/or services that have the potential to make academic and industrial research, chemical/biotech manufacturing or other biotechnology applications significantly easier and more efficient to increase success rates of such industries.

Companies

more about
DNA SCRIPT
more about
Indi molecular
more about
nanoSyrinx
more about
Pictor Labs
more about
Plexium
more about
Riffyn
more about
SciPio Bioscience

Electronics

The Electronics Fund is the strategic, corporate venture arm of the performance materials division of Merck KGaA, Darmstadt, Germany.

Electronics Team

more about
Javier Rodriguez
more about
Sebastian Schoefer
Investment Director
more about
Christian Patze
Investment Director
more about
Daniel Franke
Principal
more about
Sarah Luppino
Associate
more about
Robert Even
BD Manager Israel
more about
Owen Lozman
Managing Director
more about
Björn Kuhl
Head of Operations
more about
Radhika Ramachandran

Discovering and unleashing the most innovative startups in the Electronics sector, the fund targets companies developing applications and solutions for the future of computing, data storage, display and device miniaturization.

Companies

more about
Alcan Systems
more about
aveni
more about
Celestial.AI
more about
Electroninks
more about
Ferroelectric Memory GmbH
more about
IKAS
more about
Lumiode
more about
MemryX
more about
Metalenz
more about
Peratech
more about
PxE
more about
SeeQC
more about
Stealth Company
more about
SynSense

Frontier Tech & Sustainability

The New Businesses Fund is the strategic, corporate venture arm of Merck KGaA, Darmstadt, Germany.

Frontier Tech & Sustainability Team

more about
Javier Rodriguez
more about
Sebastian Schoefer
Investment Director
more about
Christian Patze
Investment Director
more about
Daniel Franke
Principal
more about
Sarah Luppino
Associate
more about
Robert Even
BD Manager Israel
more about
Owen Lozman
Managing Director
more about
Björn Kuhl
Head of Operations
more about
Radhika Ramachandran

This fund exists to pursue interdisciplinary approaches with opportunities that serve multiple business sectors or have a strong element of technology convergence. The Frontier Tech and Sustainability fund is looking for novel technologies, services and business models that can positively impact the sustainability of both Merck KGaA, Darmstadt, Germany and our customers, be that via novel production of materials or through innovations in the application of digital technologies.

Companies

more about
Akili
more about
Altoida
more about
Biolinq
more about
Formo
more about
Medisafe
more about
micropsi industries
more about
mosa meat
more about
Neurable
more about
Pilltracker
more about
Sonde Health
more about
Wiliot